FI943100A - Ansamycin derivatives as anthionogenic and anti-cancer agents - Google Patents

Ansamycin derivatives as anthionogenic and anti-cancer agents Download PDF

Info

Publication number
FI943100A
FI943100A FI943100A FI943100A FI943100A FI 943100 A FI943100 A FI 943100A FI 943100 A FI943100 A FI 943100A FI 943100 A FI943100 A FI 943100A FI 943100 A FI943100 A FI 943100A
Authority
FI
Finland
Prior art keywords
anthionogenic
cancer agents
ansamycin derivatives
ansamycin
derivatives
Prior art date
Application number
FI943100A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI943100A0 (en
Inventor
Randall James Gallaschun
Mikel Paul Moyer
Rodney Caughren Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI943100A0 publication Critical patent/FI943100A0/en
Publication of FI943100A publication Critical patent/FI943100A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D225/00Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
FI943100A 1993-06-29 1994-06-28 Ansamycin derivatives as anthionogenic and anti-cancer agents FI943100A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8506593A 1993-06-29 1993-06-29

Publications (2)

Publication Number Publication Date
FI943100A0 FI943100A0 (en) 1994-06-28
FI943100A true FI943100A (en) 1994-12-30

Family

ID=22189242

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943100A FI943100A (en) 1993-06-29 1994-06-28 Ansamycin derivatives as anthionogenic and anti-cancer agents

Country Status (5)

Country Link
EP (1) EP0706516A1 (en)
JP (1) JP2794342B2 (en)
CA (1) CA2166320A1 (en)
FI (1) FI943100A (en)
WO (1) WO1995001342A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU764603B2 (en) 1998-07-17 2003-08-21 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Water-soluble drugs and methods for their production
EP1169319A4 (en) * 1999-04-09 2005-02-09 Sloan Kettering Institutefor C Methods and compositions for degradation and/or inhibition of her-family tyrosine kinases
WO2002036574A1 (en) * 2000-11-06 2002-05-10 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Geldanamycin derivatives useful for the treatment of cancer
EP1373215B1 (en) * 2001-03-30 2006-07-26 THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH Geldanamycin derivatives useful for treating cancer
WO2003013430A2 (en) * 2001-08-06 2003-02-20 Kosan Biosciences, Inc. Benzoquinone ansamycins
EP1923061A1 (en) 2001-09-24 2008-05-21 Conforma Therapeutic Corporation Process for preparing 17-Allyl amino geldanamycin (17-AAG) and other ansamycins
KR20040054692A (en) 2001-09-24 2004-06-25 콘포마 세러퓨틱스 코포레이션 Process for preparing 17-allyl amino geldanamycin (17-aag) and other ansamycins
ATE433961T1 (en) 2002-02-08 2009-07-15 Conforma Therapeutics Corp ANSAMYCINS WITH IMPROVED PHARMACOLOGICAL AND BIOLOGICAL PROPERTIES
CA2518836A1 (en) * 2003-03-13 2004-09-30 Conforma Therapeutics Corporation Drug formulations having long and medium chain triglycerides
CA2545457A1 (en) 2003-11-12 2005-06-23 Kosan Biosciences, Inc. 11-o-methylgeldanamycin compounds
US6875863B1 (en) 2003-11-12 2005-04-05 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
US6887993B1 (en) 2003-11-12 2005-05-03 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
US6855705B1 (en) 2003-11-12 2005-02-15 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
US20060019941A1 (en) * 2003-12-23 2006-01-26 Infinity Pharmaceuticals, Inc. Analogs of benzoquinone-containing ansamycins and methods of use thereof
RU2484086C9 (en) 2003-12-23 2013-08-20 Инфинити Дискавэри, Инк. Analogues of benzoquinone-containing ansamycins (versions), method for production thereof, pharmaceutical composition (versions) and cancer treatment method (versions)
PE20081506A1 (en) 2006-12-12 2008-12-09 Infinity Discovery Inc ANSAMYCIN FORMULATIONS
JP5583680B2 (en) 2008-10-15 2014-09-03 インフィニティー ファーマスーティカルズ インコーポレイテッド Ansamycin hydroquinone composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3595955A (en) * 1969-03-26 1971-07-27 Upjohn Co Geldanamycin and process for producing same
US3987035A (en) * 1974-04-05 1976-10-19 University Of Illinois Foundation Biologically active compounds
US4261989A (en) * 1979-02-19 1981-04-14 Kaken Chemical Co. Ltd. Geldanamycin derivatives and antitumor drug
CA2127457A1 (en) * 1992-01-06 1993-07-22 Walter P. Cullen Process and uses for 4,5-dihydrogeldanamycin and its hydroquinone

Also Published As

Publication number Publication date
JPH08506356A (en) 1996-07-09
FI943100A0 (en) 1994-06-28
WO1995001342A1 (en) 1995-01-12
JP2794342B2 (en) 1998-09-03
CA2166320A1 (en) 1995-01-12
EP0706516A1 (en) 1996-04-17

Similar Documents

Publication Publication Date Title
FI961599A (en) 1N-alkyl-N-arylpyrimidinamines and their derivatives
ATE162199T1 (en) ANDROSTENE DERIVATIVES
FI941137A (en) 2-Debenzoyl-2-acyltaxol derivatives and methods for their preparation
EE9700190A (en) Pyrazol-4-yl-benzoyl derivatives and their use as herbicides
FI944310A0 (en) Heteroarylamino- and heteroaryl-sulfonamido-substituted 3-benzylaminomethyl-piperidines and the like
FI953479A0 (en) 1-Arylpyrimidine derivatives and their pharmaceutical use
ATA75293A (en) INDOLDER DERIVATIVES
FI943100A (en) Ansamycin derivatives as anthionogenic and anti-cancer agents
ITMI920408A1 (en) BENZOPYRANIC AND BENZOTHIOPYRANIC DERIVATIVES
DE69330497D1 (en) CHINAZOLIN DERIVATIVES
FI960867A (en) Benzazepine derivative, its pharmaceutical composition and intermediate
DE59308714D1 (en) CYCLOBUTANE-BENZENE DERIVATIVES
FI953021A0 (en) 4-Benzoyl-isoxazole derivatives and their use as herbicides
FI960076A0 (en) Novel (1-heteroazolyl-1-heterocyclyl) alkane derivatives and their use as neuroprotective agents
FI955679A0 (en) Piperidine derivatives, their preparation and use
BR9408029A (en) N-substituted 3-azabicycloalkanes derivatives
NO952288D0 (en) Benzazepinon derivatives
DE69313890D1 (en) 5-aminoflavone derivatives
EE03614B1 (en) Pyrazol-4-yl-benzoyl derivatives and their use as herbicides
DE9316475U1 (en) Eye bolt
FI943513A0 (en) 3-Phenylureidoazepin-2-ones and benzazepin-2-ones useful as cholecystokinin antagonists
DE59407726D1 (en) 3-aryl-4-hydroxy-3-dihydrofuranone derivatives
ITMI941191A0 (en) 1-B-METHYL-2-THIOL CARBAPEN DERIVATIVES
FI950303A0 (en) Pyridoindolobenzodiazepines and derivatives as antipsychotics
DE69400388T2 (en) Cyclohexenediol derivatives